UnitedHealth Group and Amedisys outlined plans to divest a significant number of home health and hospice locations as they ...
Recent developments in the legal battle over the planned $3.3 billion UnitedHealth Group (NYSE: UHG) acquisition of Amedisys (Nasdaq: AMED) have moved the ...
UnitedHealth Group said in a court filing it is working with Amedisys to identify potential buyers for at least 128 home ...
UnitedHealth Group says the Justice Department’s antitrust challenge to its proposed $3.3 billion purchase of Amedisys is wrong on the merits and threatens to deprive consumers of benefits from ...
2d
Zacks.com on MSNAmedisys (AMED) Earnings Expected to Grow: Should You Buy?Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
UnitedHealth Group has withdrawn its motion to dismiss the Justice Department’s ongoing antitrust challenge to a proposed ...
UnitedHealth Group said its motion to dismiss the DOJ lawsuit was moot after the agency cited which regions would be impacted ...
Two whistleblowers have adequately alleged that Amedisys Inc. violated the False Claims Act by improperly billing Medicare and other federal health-care programs for home health services, a New York ...
BATON ROUGE, La., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care services, has recognized 47 employees with the ...
In a report released on January 29, Whit Mayo from Leerink Partners reiterated a Hold rating on Amedisys (AMED – Research Report), with a price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results